Skip to content
10-Q

Quarterly Report

SQZ BIOTECHNOLOGIES COMPANY

0000950170-23-020606

← back to feed
Filed
May 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 4, 2023 29.49M sh
Shares Diluted Q1 2023 · Mar 31, 2023 29.49M sh
Shares Diluted Q1 2023 · Mar 31, 2022 28.15M sh
Capex Q1 2023 · Mar 31, 2023 $65K
Capex Q1 2023 · Mar 31, 2022 $228K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$23.77M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$20.43M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $39.87M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $63.71M
Stockholders Equity Q1 2023 · Mar 31, 2023 $40.16M
Stockholders Equity Q1 2023 · Dec 31, 2022 $57.15M
Stockholders Equity Q1 2023 · Mar 31, 2022 $104.91M
Stockholders Equity Q1 2023 · Dec 31, 2021 $123.98M
Current Liabilities Q1 2023 · Mar 31, 2023 $12.69M
Current Liabilities Q1 2023 · Dec 31, 2022 $21.84M
Total Liabilities Q1 2023 · Mar 31, 2023 $33M
Total Liabilities Q1 2023 · Dec 31, 2022 $42.75M
Current Assets Q1 2023 · Mar 31, 2023 $44.45M
Current Assets Q1 2023 · Dec 31, 2022 $68.2M
Total Assets Q1 2023 · Mar 31, 2023 $73.16M
Total Assets Q1 2023 · Dec 31, 2022 $99.9M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.60
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.75
Eps Basic Q1 2023 · Mar 31, 2023 −$0.60
Eps Basic Q1 2023 · Mar 31, 2022 −$0.75
Sga Expense Q1 2023 · Mar 31, 2023 $5.28M
Sga Expense Q1 2023 · Mar 31, 2022 $6.91M
Rd Expense Q1 2023 · Mar 31, 2023 $12.98M
Rd Expense Q1 2023 · Mar 31, 2022 $17.01M
Net Income Q1 2023 · Mar 31, 2023 −$17.69M
Net Income Q1 2023 · Mar 31, 2022 −$21.04M
Operating Income Q1 2023 · Mar 31, 2023 −$18.26M
Operating Income Q1 2023 · Mar 31, 2022 −$21.05M
Revenue Q1 2023 · Mar 31, 2022 $2.87M